These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30562845)

  • 1. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    Kohsaka H; Mimori T; Kanda T; Shimizu J; Sunada Y; Fujimoto M; Kawaguchi Y; Jinnin M; Muro Y; Ishihara S; Tomimitsu H; Ohta A; Sumida T
    J Dermatol; 2019 Jan; 46(1):e1-e18. PubMed ID: 30562845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    Kohsaka H; Mimori T; Kanda T; Shimizu J; Sunada Y; Fujimoto M; Kawaguchi Y; Jinnin M; Muro Y; Ishihara S; Tomimitsu H; Ohta A; Sumida T
    Mod Rheumatol; 2019 Jan; 29(1):1-19. PubMed ID: 30565491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) among dermatologists, rheumatologists and neurologists.
    Tiao J; Feng R; Bird S; Choi JK; Dunham J; George M; Gonzalez-Rivera TC; Kaufman JL; Khan N; Luo JJ; Micheletti R; Payne AS; Price R; Quinn C; Rubin AI; Sreih AG; Thomas P; Okawa J; Werth VP
    Br J Dermatol; 2017 Feb; 176(2):423-430. PubMed ID: 28004387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool-Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists.
    Tiao J; Feng R; Berger EM; Brandsema JF; Coughlin CC; Khan N; Kichula EA; Lerman MA; Lvovich S; McMahon PJ; Rider LG; Rubin AI; Scalzi LV; Smith DM; Taxter AJ; Treat JR; Williams RP; Yum SW; Okawa J; Werth VP
    Br J Dermatol; 2017 Oct; 177(4):1086-1092. PubMed ID: 28421601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; García-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J;
    Ann Rheum Dis; 2017 May; 76(5):792-801. PubMed ID: 28385805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource use.
    Christopher-Stine L; Wan GJ; Kelly W; McGowan M; Bostic R; Reed ML
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1424-1433. PubMed ID: 33119444
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of dermatomyositis and polymyositis.
    Choy EH; Isenberg DA
    Rheumatology (Oxford); 2002 Jan; 41(1):7-13. PubMed ID: 11792873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population.
    Bradford Rice J; White A; Lopez A; Galebach P; Schepman P; Popelar B; Philbin M
    J Med Econ; 2016 Jul; 19(7):649-54. PubMed ID: 26850074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.
    Tomimitsu H; Ohta A; Nagai M; Nishina M; Ishihara S; Kohsaka H
    Mod Rheumatol; 2016; 26(3):398-402. PubMed ID: 26375202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using multi-omics methods to understand dermatomyositis/polymyositis.
    Gao S; Luo H; Zhang H; Zuo X; Wang L; Zhu H
    Autoimmun Rev; 2017 Oct; 16(10):1044-1048. PubMed ID: 28778709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dermatomyositis and polymyositis: 21 cases in Senegal].
    Diallo M; Fall AK; Diallo I; Diédhiou I; Ba PS; Diagne M; Ndiaye B; Ndiaye A; Niang A; Gning SB; Ba FK; Fall F; Mbaye PS
    Med Trop (Mars); 2010 Apr; 70(2):166-8. PubMed ID: 20486354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and therapy for polymyositis and dermatomyositis].
    Kawai S
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2171-6. PubMed ID: 18044152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inflammatory myopathies].
    Cherin P
    Rev Prat; 2001 Feb; 51(3):270-7. PubMed ID: 11265423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
    Hinze CH; Speth F; Oommen PT; Haas JP
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):38. PubMed ID: 29925381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in biomarkers for dermatomyositis.
    Yang WM; Chen JJ
    Clin Chim Acta; 2018 Jul; 482():172-177. PubMed ID: 29614309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in Patients with Polymyositis and Dermatomyositis in an Israeli Population.
    Kridin K; Kridin M; Amital H; Watad A; Khamaisi M
    Isr Med Assoc J; 2020 Oct; 22(10):623-627. PubMed ID: 33070486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.
    Rider LG; Ruperto N; Pistorio A; Erman B; Bayat N; Lachenbruch PA; Rockette H; Feldman BM; Huber AM; Hansen P; Oddis CV; Lundberg IE; Amato AA; Chinoy H; Cooper RG; Chung L; Danko K; Fiorentino D; García-De la Torre I; Reed AM; Wook Song Y; Cimaz R; Cuttica RJ; Pilkington CA; Martini A; van der Net J; Maillard S; Miller FW; Vencovsky J; Aggarwal R;
    Rheumatology (Oxford); 2017 Nov; 56(11):1884-1893. PubMed ID: 28977549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Saad Magalhaes C; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
    Ann Rheum Dis; 2017 May; 76(5):782-791. PubMed ID: 28385804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient burden and resource utilization of polymyositis and dermatomyositis: A 10-year Study of National Inpatient Sample.
    Ungprasert P; Wannarong T; Cheungpasitporn W; Wijarnpreecha K; Thongprayoon C; Kroner PT
    Joint Bone Spine; 2020 Jul; 87(4):327-330. PubMed ID: 32184181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.
    Wu C; Wang Q; He L; Yang E; Zeng X
    PLoS One; 2018; 13(2):e0192491. PubMed ID: 29474373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.